New gum disease shot shows promise in early trial
Disease control
Not yet recruiting
This study tests an experimental injection called LP-005 for people with moderate-to-severe gum disease (periodontitis). About 100 adults will receive either the drug or a placebo to see if it reduces gum inflammation, bleeding, and bone loss. The goal is to control the disease a…
Phase: PHASE2 • Sponsor: Longbio Pharma (Suzhou) Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 11:37 UTC